Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$14,561,207
-$3,109,051 QoQ
Shares Held
40,211
-19.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#443
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $207,269,806 across 16 Drug Manufacturers - General names. AMGN ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,467 | $66,528,789 | |
| 2 | JNJ |
Johnson & Johnson
|
234,177 | $59,473,932 | |
| 3 | ABBV |
AbbVie Inc.
|
111,021 | $27,937,324 | |
| 4 | AMGN |
Amgen Inc
This page
|
40,211 | $14,561,207 | |
| 5 | MRK |
Merck & Co., Inc.
|
112,376 | $14,440,316 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
128,389 | $7,397,774 | |
| 7 | PFE |
Pfizer Inc
|
197,145 | $4,747,251 | |
| 8 | NVS |
Novartis AG
|
25,239 | $3,955,456 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,561,207 | 40,211 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $17,670,258 | 50,221 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $11,634,888 | 35,547 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $10,102,477 | 35,799 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,959,420 | 35,670 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $10,563,102 | 33,905 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,918,579 | 34,218 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $11,444,899 | 35,520 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,257,733 | 32,830 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,907,363 | 17,260 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,105,154 | 17,725 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,829,079 | 17,968 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,778,114 | 17,017 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,882,021 | 16,058 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,275,253 | 16,278 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,773,646 | 16,742 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,110,310 | 16,894 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,053,386 | 16,762 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,412,794 | 15,170 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,223,986 | 15,161 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,650,887 | 14,978 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,708,015 | 14,903 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,914,925 | 12,678 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,169,629 | 12,471 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,978,911 | 12,630 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,536,557 | 12,512 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||